Bypassing an IPO Weds Strange Bedfellows in Burgers and Biotech

Bookmark
(Bloomberg) -- A burger chain and cancer drug developer have struck a bargain to trade places amid market tumult, bypassing the IPO process.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.